The test may identify Mesothelioma

Mesothelioma malignant diseases recorded increased worldwide. Like many cancers, early detection is the key to survival, quality of life better patients. Now, a group of Japanese researchers pave the way testing laboratory to help doctors to identify disease-and begin a treatment aggressive-in the past.

Writing journal, modern pathology, the researchers explain how a protein called CD146 can’t be a biomarker for mesothelioma. There already is a protein to be patients with advanced melanoma, malignant diseases, prostate cancer ovarian cancer. Now, for the first time, researchers can also detect the presence of liquid lung mesothelioma patients.

The research team tested liquid lung patients 51, 23 was mesothelioma malignant diseases and lung condition called harmful 28 mesothelium ???????. Although the Hospital experienced symptoms are the same and all fluids, patients with vasm presence mesothelioma malignant diseases of CD146 positive. The researchers reported that the protein was those in all cases of the mesothelium ???????. They use to identify and approve CD146 90 percent of patients with malignant diseases mesothelioma.

Caused exclusively by exposure to asbestos and mesothelioma is very difficult to diagnose. Its symptoms, which can include shortness of breath, cough, you can mimic other diseases and CT scans even often not definitive. As a result, in some cases of mesothelioma are not recognized until the advanced stage of the disease, treatment options are limited. Japanese scholars wrote, “we offer CD146 is sensitive and immunocytochemical marker, allowing a complete diagnosis of mesothelioma pleural malignant diseases from the mesothelium ???????.”